Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan versus omeprazole for functional dyspepsia
TCTR20201214004Phase 0Completed
- Sponsor
- Gastroenterological Association of Thailand
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, open-label trial of vonoprazan and omeprazole in functional dyspepsia (FD) (2 arms), sponsored by Gastroenterological Association of Thailand. Primary endpoint: Efficacy in treatment dyspepsia. Started Jul 2020; status: completed.
02
Drugs
vonoprazanomeprazole
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on TCTR20201214004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201214004.